Symptom-centric view
Rheumatoid arthritis
Substances reporting Rheumatoid arthritis disproportionately — ranked by ROR.
showing 9 of 9
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
tretinoin Retin-A · Atralin | 4.4 [3.8–5.1] | 201 | injectables | new |
nicotinamide Niacinamide | 26.7 [23.7–30.1] | 304 | longevity | new |
| 14.4 [14.2–14.5] | 36,515 | algemeen | new | |
| 5.7 [5.5–5.9] | 4,521 | algemeen | new | |
| 7.4 [7.2–7.5] | 8,866 | algemeen | new | |
| 25.3 [24.1–26.7] | 1,648 | algemeen | new | |
| 7.4 [7.2–7.5] | 8,869 | algemeen | new | |
| 3.8 [3.7–3.9] | 12,380 | algemeen | new | |
| 50.3 [49.5–51.1] | 23,924 | algemeen | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).